Michael M. Silverman

Michael M. Silverman is a specialized pharmaceutical and biotechnology consulting firm that provides strategic guidance on regulatory affairs and clinical development. The firm focuses on assisting life science companies with FDA interactions, including the preparation and submission of IND, NDA, and BLA applications. With expertise spanning CMC (Chemistry, Manufacturing, and Controls), clinical trial design, and project management, the consultancy helps bridge the gap between early-stage research and commercial approval. The firm is led by Dr. Michael M. Silverman, a recognized expert in the regulatory process and author of the widely used industry textbook, "The Pharmaceutical Regulatory Process." His deep understanding of the regulatory landscape makes the firm a critical partner for companies navigating the complexities of drug development.